NCT03254927 2023-04-03A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell CarcinomaCelldex TherapeuticsPhase 2 Terminated30 enrolled 17 charts
NCT03162224 2022-08-25Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck CancerMedImmune LLCPhase 1/2 Completed35 enrolled 25 charts
NCT03049280 2020-10-06Prospective, Multicenter da Vinci® SP™ Surgical System TORS StudyIntuitive SurgicalPhase NA Completed33 enrolled 8 charts